BOTULISM IN PREGNANT WОMEN

Four members of a single family were hospitalized in the Central District Hospital of B. Gafurov District on December 9, 2023, because they had weakness in the limbs, nausea and vomiting, and visual impairments after consuming home-canned products. Three patients were transferred in seri-ous condition to the infectious diseases department, and a pregnant woman and a patient were transferred to the ICU of the same hospital. All patients were treated with botulinum antitoxin as outlined in the protocol. The mother-in-law of the pregnant woman died after four days of being hospitalized, and the hus-band and son were treated and released. This article presents a clinical case of botulism in a 32-week pregnant woman who initially devel-oped neurological symptoms, followed by progressive respiratory dysfunction. Botulinum antitoxin was administered during pregnancy. An emergency cesarean section was performed because of vital distressing signs and symptoms. An infant boy was born alive prematurely with a birth weight of 1750 grams, a length of 42 cm, and 5-minute Apgar scores of 5 and 7. The baby was managed by a neonatal intensive care team from the maternity department. A heavily pregnant mother was managed over three weeks with consultation of infectious disease and obstetric-gynecological consultants.